Myeloma bone disease
- 31 July 2001
- journal article
- Published by Elsevier BV in Seminars in Hematology
- Vol. 38 (3), 276-285
- https://doi.org/10.1016/s0037-1963(01)90020-4
Abstract
No abstract availableKeywords
This publication has 72 references indexed in Scilit:
- Biochemical markers of bone metabolism reflect osteoclastic and osteoblastic activity in multiple myelomaEuropean Journal of Haematology, 2000
- A Dose-Finding Study of Zoledronate in Hypercalcemic Cancer PatientsJournal of Bone and Mineral Research, 1999
- Osteoprotegerin Ligand Is a Cytokine that Regulates Osteoclast Differentiation and ActivationCell, 1998
- Role of cytokines in bone resorptionBone, 1995
- Treatment of Hypercalcaemia with Pamidronate in Patients with end Stage Renal FailureScandinavian Journal of Urology and Nephrology, 1993
- Changing clinical presentation of multiple myelomaEuropean Journal of Cancer and Clinical Oncology, 1991
- Metastatic Bone DiseaseClinical Orthopaedics and Related Research, 1990
- Serum levels of interleukin 6, a potent myeloma cell growth factor, as a reflect of disease severity in plasma cell dyscrasias.JCI Insight, 1989
- Interleukin-1 and tumor necrosis factor stimulate the formation of human osteoclastlike cells in vitroJournal of Bone and Mineral Research, 1989
- Production of Lymphotoxin, a Bone-Resorbing Cytokine, by Cultured Human Myeloma CellsNew England Journal of Medicine, 1987